π₯ Novartis Halts Cell Therapy Trials Post-Deaths
Novartis has paused its autoimmune cell therapy studies following reports of patient deaths. The clinical trials were being conducted across various locations globally. The pause comes after incidents occurred during the trials in recent months. This decision is a significant step back for the ongoing research in this area. The company is now reviewing the safety data before deciding on the next steps.